# Subclinical Hypothyroidism > Subclinical hypothyroidism TSH thresholds, TPO antibodies, levothyroxine indications and pregnancy targets for NEET-PG Medicine preparation. - Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/subclinical-hypothyroidism - Exam / course: NEET-PG · Subject: Medicine - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Subclinical Hypothyroidism", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/subclinical-hypothyroidism ## Direct answer A mildly raised TSH with a normal free T4 defines subclinical hypothyroidism, and about 90% of cases sit between 4.5 and 10 mIU/L. Many are transient — TSH fluctuates by up to 20% day to day — so the diagnosis needs a confirmatory repeat. Treat with levothyroxine when TSH is above 10 mIU/L, when TPO antibodies are positive, in pregnancy or goitre, or when symptoms are convincing; otherwise recheck at 6–8 weeks and follow annually. The art is avoiding overtreatment, which converts a biochemical curiosity into iatrogenic thyrotoxicosis. ## What you must remember - Diagnostic pattern: TSH 4.5–10 mIU/L (roughly 90% of cases) with normal free T4; TSH above 10 with normal T4 is still "subclinical" but treated like overt disease. - Always repeat TSH after 6–8 weeks before labelling — non-thyroidal illness recovery and assay variability both produce false rises. - TPO antibody positivity predicts progression to overt hypothyroidism (a few per cent per year) and tips the balance toward treatment. - Treat when: TSH >10 mIU/L, positive TPO, pregnancy or planned pregnancy, goitre, or rising TSH on serial testing with symptoms. - Starting dose 25–50 µg daily — lower than the full replacement used in overt hypothyroidism; recheck TSH at 6–8 weeks. - Overtreatment in the elderly risks atrial fibrillation and accelerated bone loss — a repeated NEET-PG point. - Pregnancy targets by trimester: TSH 0.1–2.5 (first), 0.2–3.0 (second), 0.3–3.5 mIU/L (third); levothyroxine requirement rises by roughly 30% from the first trimester. - Untreated patients need annual TSH: a substantial minority normalise, most stay stable, a minority progress. ## How to work through a real case A 34-year-old woman presents with fatigue and a mildly irregular cycle; TSH is 6.8 mIU/L with a normal free T4. Step one is to confirm — repeat TSH with TPO antibodies after 6–8 weeks. Suppose TSH is now 6.2 and TPO is strongly positive. She is young, symptomatic, and likely to progress, so start levothyroxine 25–50 µg before breakfast and recheck TSH at 6–8 weeks, titrating in 12.5–25 µg steps until TSH sits between 1 and 3. Contrast her with a 78-year-old woman with the same TSH of 6.5, normal free T4, negative TPO, and osteopenia. Here the arithmetic changes: the absolute benefit of treatment is small, the risk of over-replacement is real, and guidelines favour observation with annual TSH. If she develops atrial fibrillation and is started on amiodarone, recheck thyroid function every six months because the drug can push her in either direction. Now make the same woman pregnant at 34: the moment conception is confirmed, levothyroxine is increased — practically, two extra tablets per week (nine instead of seven) achieves the ~30% dose rise. TSH is checked each trimester against trimester-specific reference ranges, and after delivery the dose returns to the pre-pregnancy level with a TSH recheck at six weeks. This escalation-with-pregnancy step is a viva favourite because candidates remember to treat but forget to increase. ## Where students slip The classic error is treating the number, not the patient: a TSH of 7 gets full-dose 100 µg replacement, the TSH plunges to 0.05, and the patient returns with palpitations — the examiner then asks who caused the thyrotoxicosis. The second slip is diagnosing subclinical hypothyroidism during acute illness. A TSH of 12 in a patient with sepsis or recovering from surgery may reflect euthyroid sick syndrome, not thyroid failure; repeat after recovery. Third, candidates quote a single universal pregnancy TSH target instead of trimester-specific ranges, and forget that in pregnancy the levothyroxine tablet is taken separately from iron and calcium tablets by at least four hours, since both impair absorption. ## Frequently asked questions ### At what TSH level should subclinical hypothyroidism be treated even without symptoms? Treatment is advised when TSH is above 10 mIU/L, because progression to overt disease is likelier and the threshold for benefit is clearer. Between 4.5 and 10, treatment is individualised using TPO status, age, symptoms, goitre and pregnancy plans. ### How does TPO antibody status change management? Positive TPO antibodies mark autoimmune thyroiditis and predict progression to permanent overt hypothyroidism. They tilt decisions toward treatment and closer follow-up in borderline cases. ### What dose of levothyroxine is started in subclinical disease? Usually 25–50 µg daily, titrated to a TSH of roughly 1–3 mIU/L. Full replacement doses (1.6 µg/kg) are reserved for overt hypothyroidism. ### How is subclinical hypothyroidism managed in pregnancy? Overt and subclinical hypothyroidism in pregnancy are treated, with trimester-specific TSH targets (0.1–2.5 in the first trimester). The dose is increased by about 30% at confirmation of pregnancy and TSH is monitored each trimester. ### Can subclinical hypothyroidism resolve without treatment? Yes — a meaningful proportion normalise on repeat testing, which is precisely why a confirmatory TSH after 6–8 weeks precedes any prescription. Annual surveillance suffices when the decision is not to treat.